Strong Financial Performance

GE HealthCare Technologies Inc. has announced a remarkable start to fiscal 2025, with a 3% year-on-year revenue increase to $4.8 billion, exceeding market expectations.

Significant Growth in Net Income and EPS

The company's net income saw a substantial 50.8% rise compared to the same quarter in 2024, reaching $564 million. Diluted earnings per share (EPS) also experienced a 51.85% annual increase, settling at $1.23. In a move to return value to shareholders, GE HealthCare unveiled a $1 billion share repurchase program.

Leadership's Vision

CEO Peter Arduini highlighted the company's strong execution and robust growth in revenue, orders, and profit, particularly in the U.S. He also emphasized the strategic acquisition of Nihon Medi-Physics, aimed at enhancing global access to next-generation radiopharmaceuticals.

Market Reaction

Following the announcement, GE HealthCare's stock price increased by 2.81% in premarket trading, reaching $70 per share at 6:29 am ET.